Brain metastases in patients with salivary duct carcinoma: A retrospective study

Area of Science:

• Oncology
• Cancer Research
• Clinical Prognostics

Background:

• Salivary duct carcinoma (SDC) is an aggressive adenocarcinoma with a low 5-year survival rate.
• Brain metastasis (BM) is a significant complication in SDC, yet its prognostic impact is not well-defined.
• Understanding BM incidence and prognosis is crucial for improving SDC patient outcomes.

Purpose of the Study:

• To determine the incidence of brain metastasis (BM) in salivary duct carcinoma (SDC) patients.
• To identify prognostic factors influencing overall survival (OS) in SDC patients with BM.
• To develop a novel prognostic tool for SDC patients with BM.

Main Methods:

• Retrospective analysis of 464 SDC patients from a multicenter study.
• Investigation of BM incidence, OS rates, and prognostic factors.
• Development and validation of the SDC-graded prognostic assessment (GPA) score.

Main Results:

• 14% of SDC patients (65/464) developed BM.
• Median OS for SDC patients with BM was 13.1 months.
• Poor OS was associated with ECOG Performance Status >1, HER2-negative status, and uncontrolled locoregional disease.

Conclusions:

• The SDC-GPA score effectively stratifies prognosis for SDC patients with BM.
• The SDC-GPA score provides valuable prognostic information for clinical decision-making.
• Further research can refine the SDC-GPA score for enhanced patient care.